FIRST-IN-HUMAN PHASE I/II CLINICAL TRIAL OF IG-TREGS FOR GVHD PREVENTION

被引：0
|
作者：
Lysandrou, Memnon [1 ]
Kefala, Dionysia [1 ]
Christofi, Panagiota [1 ,2 ]
Liga, Maria [1 ]
Miggos, Antonis [3 ]
Papagregoriou, Charys [4 ]
Vlachonikola, Elisavet [3 ]
Savvopoulos, Nikolaos [1 ]
Zacharioudaki, Vassiliki [1 ]
Vallianou, Ioanna [2 ]
Sagiadinou, Eleutheria [1 ]
Tsokanas, Dimitris [1 ]
Theodorellou, Rodanthy [5 ]
Papadopoulou, Anastasia [2 ]
Triantafyllou, Evi [1 ]
Sakellari, Ioanna [2 ]
Costeas, Paul [4 ,6 ]
Chatzidimitriou, Anastasia [3 ]
Yannaki, Evangelia [2 ]
Spyridonidis, Alexandros [1 ]
机构：
[1] Univ Patras, Univ Gen Hosp Patras, Patras, Greece
[2] George Papanikolaou Hosp, Thessaloniki, Greece
[3] Ctr Res & Technol Hellas, Inst Appl Biosci, Thessaloniki, Greece
[4] Ctr Study Hematol & Other Malignancies, Nicosia, Cyprus
[5] Pharmassist Ltd, Athens, Greece
[6] Karaiskakio Fdn, Nicosia, Cyprus
来源：
BONE MARROW TRANSPLANTATION | 2024年 / 59卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P568
引用
收藏
页码：534 / 535
页数：2
相关论文
共 50 条
  • [21] Choice of Starting Dose for Biopharmaceuticals in First-in-Human Phase I Cancer Clinical Trials
    Hansen, Aaron R.
    Cook, Natalie
    Ricci, M. Stacey
    Razak, Albiruni
    Le Tourneau, Christophe
    McKeever, Kathleen
    Roskos, Lorin
    Dixit, Rakesh
    Siu, Lillian L.
    Hinrichs, Mary Jane
    ONCOLOGIST, 2015, 20 (06): : 653 - 659
  • [22] A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles encoding shared tumor antigens for immunotherapy of malignant melanoma
    Jabulowsky, R. A.
    Loquai, C.
    Derhovanessian, E.
    Mitzel-Rink, H.
    Utikal, J.
    Hassel, J.
    Kaufmann, R.
    Pinter, A.
    Diken, M.
    Gold, M.
    Heesen, L.
    Schreeb, K. H.
    Schwarck-Kokarakis, D.
    Kreiter, S.
    Gaiser, M. R.
    Jaeger, D.
    Grabbe, S.
    Tuereci, O.
    Sahin, U.
    ANNALS OF ONCOLOGY, 2018, 29 : 439 - 439
  • [23] First-in-human phase I trial of NHS-IL12 in advanced solid tumors
    Kim, Joseph W.
    Heery, Christopher Ryan
    Bilusic, Marijo
    Singh, Nishith K.
    Madan, Ravi A.
    Sabzevari, Helen
    Schlom, Jeffrey
    Gulley, James L.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [24] A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles encoding shared tumor antigens for immunotherapy of malignant melanoma
    Jabulowsky, Robert A.
    Loquai, Carmen
    Mitzel-Rink, Heidrun
    Utikal, Jochen
    Gebhardt, Christoffer
    Hassel, Jessica C.
    Kaufmann, Roland
    Pinter, Andreas
    Derhovanessian, Evelyna
    Anft, Christine
    Attig, Sebastian
    Deubel, Alexandra
    Diken, Mustafa
    Gold, Maike
    Guertler, Claudia
    Haas, Heinrich
    Heesen, Ludwig
    Kemmer-Brueck, Alexandra
    Kranz, Lena M.
    Kuehlcke, Klaus
    Kuhn, Andreas
    Langguth, Peter
    Luxemburger, Ulrich
    Maurus, Daniel
    Meng, Martin
    Mueller, Felicitas
    Rae, Richard
    Sari, Fatih
    Schreeb, Katharina
    Schwarck-Kokarakis, Doreen
    Stein, Malte
    Jaeger, Dirk
    Grabbe, Stephan
    Kreiter, Sebastian
    Huber, Christoph
    Tuereci, Oezlem
    Sahin, Ugur
    CANCER RESEARCH, 2018, 78 (13)
  • [25] Commencement of first-in-human phase I/II TCR-T clinical trial targeting shared tumor-specific hotspot mutations in solid tumors
    Morelli, M. P.
    Negrao, M. V.
    Jazaeri, A.
    Johnson, B.
    Kebriaei, P.
    Deniger, D.
    Collinson-Pautz, M.
    Demars, N.
    Heymach, J.
    Kopetz, S.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S897 - S897
  • [26] A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles encoding shared tumor antigens for potent melanoma immunotherapy
    Heesen, L.
    Jabulowsky, R.
    Loquai, C.
    Utikal, J.
    Gebhardt, C.
    Hassel, J.
    Kaufmann, R.
    Pinter, A.
    Derhovanessian, E.
    Diken, M.
    Kranz, L.
    Haas, H.
    Attig, S.
    Kuhn, A.
    Langguth, P.
    Schwarck-Kokarakis, D.
    Jaeger, D.
    Grabbe, S.
    Tuereci, Oe.
    Sahin, U.
    ANNALS OF ONCOLOGY, 2017, 28
  • [27] An Open-Label, First-in-Human, Phase I Trial of Daily Pclx-001
    Sangha, Randeep
    Mackey, John R.
    Sehn, Laurie H.
    Kuruvilla, John
    Weickert, Michael J.
    Berthiaume, Luc G.
    BLOOD, 2021, 138
  • [28] A Phase I First-in-Human Trial of Bardoxolone Methyl in Patients with Advanced Solid Tumors and Lymphomas
    Hong, David S.
    Kurzrock, Razelle
    Supko, Jeffrey G.
    He, Xiaoying
    Naing, Aung
    Wheler, Jennifer
    Lawrence, Donald
    Eder, Joseph Paul
    Meyer, Colin J.
    Ferguson, Deborah A.
    Mier, James
    Konopleva, Marina
    Konoplev, Sergej
    Andreeff, Michael
    Kufe, Donald
    Lazarus, Hillard
    Shapiro, Geoffrey I.
    Dezube, Bruce J.
    CLINICAL CANCER RESEARCH, 2012, 18 (12) : 3396 - 3406
  • [29] First-in-human clinical trial guidelines under review in EU
    Reactions Weekly, 2016, 1605 (1) : 2 - 2
  • [30] A first-in-human phase I/II trial of the oral HIF-2a inhibitor PT2977 in patients with advanced RCC
    Jonasch, E.
    Plimack, E. R.
    Bauer, T.
    Merchan, J. R.
    Papadopoulos, K. P.
    McDermott, D. F.
    Michaelson, M. D.
    Appleman, L. J.
    Thamake, S.
    Zojwalla, N.
    Choueiri, T. K.
    ANNALS OF ONCOLOGY, 2019, 30
12345